ficusin has been researched along with bexarotene in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Junkins-Hopkins, JM; McGinnis, KS; Rook, AH; Shapiro, M; Vittorio, CC | 1 |
| Huber, MA; Kunzi-Rapp, K; Scharffetter-Kochanek, K; Staib, G | 1 |
| Cowper, S; Girardi, M; Huang, J; Moss, J | 1 |
| Beyer, M; Erdmann, R; Humme, D; Nast, A; Vandersee, S | 1 |
2 review(s) available for ficusin and bexarotene
| Article | Year |
|---|---|
Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy: An effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma.
Topics: Aged; Anticarcinogenic Agents; Bexarotene; Drug Therapy, Combination; Female; Ficusin; Humans; Male; Middle Aged; Photosensitizing Agents; PUVA Therapy; Sezary Syndrome; Skin Neoplasms; Tetrahydronaphthalenes | 2003 |
Systematic review of combination therapies for mycosis fungoides.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Combined Modality Therapy; Deoxycytidine; Ficusin; Gemcitabine; Humans; Hydroxamic Acids; Interferon-alpha; Methotrexate; Mycosis Fungoides; Phototherapy; Retinoids; Skin Neoplasms; Tetrahydronaphthalenes; Vorinostat | 2014 |
2 other study(ies) available for ficusin and bexarotene
| Article | Year |
|---|---|
Management of refractory early-stage cutaneous T-cell lymphoma (mycosis fungoides) with a combination of oral bexarotene and psoralen plus ultraviolet bath therapy.
Topics: Administration, Oral; Aged; Anticarcinogenic Agents; Bexarotene; Drug Therapy, Combination; Ficusin; Humans; Male; Mycosis Fungoides; Tetrahydronaphthalenes; Ultraviolet Therapy | 2004 |
Case experience of 308-nm excimer laser therapy compatibility with PUVA and oral bexarotene for the treatment of cutaneous lesions in mycosis fungoides.
Topics: Administration, Oral; Anticarcinogenic Agents; Bexarotene; Combined Modality Therapy; Ficusin; Follow-Up Studies; Humans; Lasers, Excimer; Male; Middle Aged; Mycosis Fungoides; Photosensitizing Agents; PUVA Therapy; Skin Neoplasms; Tetrahydronaphthalenes | 2013 |